Keith Berndston, MD

Internal Medicine, Board Member (USA) - International Society for Environmentally Acquired Illness

Since 2007 Dr. Keith Berndston has been a self-employed physician who helps patients with complex, treatment-resistant health problems. His experience with and expertise in the adverse health effects of recurring exposure to inhaled bio-contaminants found in damp buildings began in 2010. He has assembled an annotated bibliography of scientific studies and review papers that document and describe the toxic and inflammatory effects of such exposures. He was invited to address indoor mold illness for the Icelandic Medical Association in January 2017. He also was invited to speak at a symposium in Australia on the subject of indoor mold illness. He has created and presented more than a dozen distinct slide lectures on the subject damp buildings and indoor mold illness in the past 6 years. His 2013 review of immune evasion and persistence in Lyme disease has been downloaded over 6,000 times. His slides on mast cell disorders, posted on Slideshare, have been viewed 29,900 times. His experience with EMF is more recent. He attended the 2019 EMF conference and has done extensive reviews of the scientific literature on adverse health effects of various types of EMF in preparation for his presentation for EMFMC 2021, with a focus on the adverse effects of prolonged exposure to extremely low frequency EMF, or ELF-EMF.


Indoor Mold Illness: Pathophysiology, Diagnosis and Treatment. Review of the Basics

Physicians are increasingly confronted with health problems with unidentified causes. Chronic illnesses with non-specific symptoms are on the rise. Scientific studies and empirical observations indicate interactions between EMF exposure and both new and pre-existing health problems. Understanding EMF alone presents a challenge for physicians. The complexity of the physician’s task increases when EMF exposures interact with bodily systems disrupted by indoor mold illness. Such concomitant exposures can create treatment-resistant patients despite receiving evidence-based treatment for comorbid conditions. This talk will explore what evidence exists to support adverse interactions between EMF and indoor mold exposures.

8:30 - 9:00 AM

Saturday 30 January 2021

Indoor Mold Illness: Pathophysiology, Diagnosis and Treatment. Review of the Basics